Drugs / SPS4251
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01743118 | Mar → Jul 2013 | psoriasis | Circassia Limited | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SPS4251 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01743118 ↗ |
| Action | Inhibit | “selective blockers of a lymphocyte potassium channel” NCT01743118 ↗ |
| Route | Topical | “will be topically applied” NCT01743118 ↗ |